In the present paper, the studies are channeled towards an evaluation of the incidence of infections with hepatic viruses (B and C) by immunoenzymatic methods, using commercial kits. The study was performed on all cases registered in January and February in 2019 (1342 patients). The following markers were used: hepatitis B virus surface antigen (AgHBs) for hepatitis B virus infection and hepatitis C virus antigen antibody (anti-HCV Ac) antibody for hepatitis C virus infection and enzyme transaminases activity was determined (TGO and TGP). The presented results allow us to state that viral hepatitis B and C are still a major public health problem, affecting all age categories of the population (small children and infants, young, adults and elderly). In January and February 2019, the age group most affected by AgHBs was 55-64 years old in men, the age group 25-34 years old being the dominant age group. 50 patients with HCV antibodies were present (4.72%), 25 men (1.86%) and 25 women (1.86%) in January and February. The age group with the highest incidence was 55-64 years in both men (36.36%) and women (36%). For 2019, in the two months of study - January and February - of the 1342 people investigated, 125 were positive for both viral markers, AgHBs and AntiHCV.
